about
A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomasSerum proteomics of glioma: methods and applications.Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy.Sequentially Programmed Magnetic Field Therapy in the Management of Recurrent Anaplastic Astrocytoma: A Case Report and Literature Review.Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.The prognosis of anaplastic astrocytoma with radiologic necrosis mimicking glioblastoma.FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan.Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology).The role of chemotherapy in anaplastic astrocytoma patients.Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma.MicroRNA-544 inhibits glioma proliferation, invasion and migration but induces cell apoptosis by targeting PARK7Molecularly targeted therapies for malignant gliomas.Diagnostic segregation of human brain tumours using Fourier-transform infrared and/or Raman spectroscopy coupled with discriminant analysisA 16-gene signature distinguishes anaplastic astrocytoma from glioblastoma.Prognostic markers of astrocytoma: how to predict the unpredictable?Update on bevacizumab and other angiogenesis inhibitors for brain cancer.Influence of insurance status and income in anaplastic astrocytoma: an analysis of 4325 patients.Anaplastic astrocytoma: prognostic factors and survival in 4807 patients with emphasis on receipt and impact of adjuvant therapy.Raman spectroscopic grading of astrocytoma tissues: using soft reference information.Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma.DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.Downregulation of miR-544 in tissue, but not in serum, is a novel biomarker of malignant transformation in glioma.Ependymal enhancement on magnetic resonance imaging for the identification of high-grade gliomas.Comparison of chemoradiotherapy with radiotherapy alone for "biopsy only" anaplastic astrocytoma.Anaplastic astrocytoma.Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes.Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma.Tumor blood volume: a prognostic biomarker for anaplastic astrocytomas?Prognostic factors and outcomes in anaplastic gliomas: An institutional experience.
P2860
Q33375377-8DEA8492-40D5-4F47-A4D7-1E4715AF428DQ33509599-197F0011-417A-4560-B99B-87D2BFFCE502Q33519196-69DB23A0-E718-4E12-8974-344F6BF33891Q33672838-93C3AC7C-7D99-41D5-B6B8-D3AB384A0C79Q33809397-73704EDA-9778-4D1D-979B-C92CE919B0F2Q33973844-36F9B6E6-A17B-499B-A1BE-C76F234DF51DQ34349906-61F3D941-8D7E-441C-ACB6-2D9D58A33805Q35914501-DBFB2B35-0DF2-4311-866E-4AE230260D29Q36010125-548300C0-84BB-4A0A-8D7C-0759DB37976AQ36041149-732459F0-67BD-4807-9038-966BA0EF9534Q36732622-67680A30-808E-4253-8C16-BC521C586DB0Q36879610-BAE7E361-3E77-4806-B926-9D3A32918C54Q37107374-0C08DDDB-E4AF-4B52-82D5-7FF1EF7F33B5Q37211899-DBDC6A1E-8BE9-4B5E-AF11-45EBABBBD3ADQ37514165-710B9C85-BF9A-4D7F-9DFE-0FE14B4A8304Q38089921-9C8C2AE4-C2DF-40C0-853E-41B18B8B9583Q38106370-90A42F3B-70F6-4CA3-B2BB-DD8EB7A2B692Q39172839-A5833E86-81E3-44FB-AFE2-68DBDE37E12FQ39613251-FF373692-1A21-4FE6-9439-FA6013B64F01Q39754659-F7352907-5C76-4FFF-8777-4BF1530AB211Q40051006-616A8693-D683-494B-8ADB-5B9C0C93F6DBQ42013769-EAD0F9F9-F83B-405C-ACA0-BFFCB7C781ABQ42119044-A127B38A-4FB0-4DFB-9631-961513F1C0FCQ42276222-255AE8C7-6F5B-4420-9A3F-CBA78BED72D8Q42366659-D4BE2E9D-8328-4C47-887D-4972BEBD6CE1Q44125195-638097A0-9201-418A-A002-4CF62CD076F1Q44610607-91CFE87B-AFC7-4967-AAE9-B49CBDB6FEEFQ46071407-DCDB1FB4-2F4E-4D9A-9B84-C659012E9D14Q48641566-3B5CDB93-86C1-4DD4-A8A8-8734CED42A40Q55004492-DB1620DF-7D42-4E18-9DF9-02F4A3D90B05
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Anaplastic astrocytoma in adults.
@ast
Anaplastic astrocytoma in adults.
@en
Anaplastic astrocytoma in adults.
@nl
type
label
Anaplastic astrocytoma in adults.
@ast
Anaplastic astrocytoma in adults.
@en
Anaplastic astrocytoma in adults.
@nl
prefLabel
Anaplastic astrocytoma in adults.
@ast
Anaplastic astrocytoma in adults.
@en
Anaplastic astrocytoma in adults.
@nl
P2093
P1476
Anaplastic astrocytoma in adults
@en
P2093
Charles Vecht
Elena Mazza
Michele Reni
Roger Stupp
P356
10.1016/J.CRITREVONC.2007.03.003
P50
P577
2007-05-02T00:00:00Z